Management of Gastrointestinal and Urogenital (GI/GU) Bleedings in Atrial Fibrillation Patients Using Pradaxa

Clinical trial NCT02022020 · COMPLETED

Trial details

NCT number: NCT02022020
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Study type: OBSERVATIONAL

Atrial Fibrillation

Start date: 2014-01-01
Primary completion: 2015-10-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.